首页 > 最新文献

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia最新文献

英文 中文
The Presence of a Reticulated Trabecula-Like Structure Increases the Risk for the Recurrence of Primary Spontaneous Pneumothorax after Thoracoscopic Bullectomy. 网状小梁样结构的存在增加了胸腔镜大球切除术后原发性自发性气胸复发的风险。
H. Ota, H. Kawai, S. Kuriyama
INTRODUCTIONDeteriorated alveolar structure at the base of blebs and bullae is known as the reticulated trabecula-like structure. Its clinical significance in primary spontaneous pneumothorax (PSP) remains unclear. This study aimed to investigate the impact of the structure on recurrence of PSP after video-assisted thoracoscopic surgery (VATS) bullectomy.METHODSBetween April 2010 and March 2014, 80 cases of PSP in 76 patients who underwent VATS bullectomy using endoscopic staplers were included. The staple line was covered with polyglycolic acid sheets and fibrin glue. Cases were assigned to a normal alveolar structure (NAS) group (n = 54) and a reticulated trabecula-like structure (RT) group (n = 26) based on the histological analysis. Factors associated with recurrence were analysed using logistic regression.RESULTSThe reticulated trabecula-like structure was significantly related to apical lung blebs. The recurrence rate of PSP was significantly higher in the RT group than in the NAS group (38.5% vs. 3.7%; P <0.001). On multivariate analysis, the reticulated trabecula-like structure was an independent factor for recurrence of PSP after VATS bullectomy.CONCLUSIONThe change of alveolar structure at the base of apical lung blebs would increase the risk for recurrence of PSP after VATS bullectomy.
泡和大泡底部恶化的肺泡结构被称为网状小梁样结构。其在原发性自发性气胸(PSP)中的临床意义尚不清楚。本研究旨在探讨胸腔镜(VATS)大球切除术后软组织结构对PSP复发的影响。方法选取2010年4月~ 2014年3月行内镜吻合器VATS大球切除术的76例患者中80例PSP。用聚乙醇酸片和纤维蛋白胶覆盖短钉线。根据组织学分析将病例分为正常肺泡结构组(NAS) 54例和网状小梁样结构组(RT) 26例。采用logistic回归分析与复发相关的因素。结果网状小梁样结构与肺尖泡明显相关。RT组PSP复发率明显高于NAS组(38.5% vs 3.7%;P < 0.001)。在多因素分析中,网状小梁样结构是VATS大球切除术后PSP复发的独立因素。结论肺尖泡底肺泡结构的改变会增加VATS大泡切除术后PSP复发的风险。
{"title":"The Presence of a Reticulated Trabecula-Like Structure Increases the Risk for the Recurrence of Primary Spontaneous Pneumothorax after Thoracoscopic Bullectomy.","authors":"H. Ota, H. Kawai, S. Kuriyama","doi":"10.5761/atcs.oa.15-00306","DOIUrl":"https://doi.org/10.5761/atcs.oa.15-00306","url":null,"abstract":"INTRODUCTION\u0000Deteriorated alveolar structure at the base of blebs and bullae is known as the reticulated trabecula-like structure. Its clinical significance in primary spontaneous pneumothorax (PSP) remains unclear. This study aimed to investigate the impact of the structure on recurrence of PSP after video-assisted thoracoscopic surgery (VATS) bullectomy.\u0000\u0000\u0000METHODS\u0000Between April 2010 and March 2014, 80 cases of PSP in 76 patients who underwent VATS bullectomy using endoscopic staplers were included. The staple line was covered with polyglycolic acid sheets and fibrin glue. Cases were assigned to a normal alveolar structure (NAS) group (n = 54) and a reticulated trabecula-like structure (RT) group (n = 26) based on the histological analysis. Factors associated with recurrence were analysed using logistic regression.\u0000\u0000\u0000RESULTS\u0000The reticulated trabecula-like structure was significantly related to apical lung blebs. The recurrence rate of PSP was significantly higher in the RT group than in the NAS group (38.5% vs. 3.7%; P <0.001). On multivariate analysis, the reticulated trabecula-like structure was an independent factor for recurrence of PSP after VATS bullectomy.\u0000\u0000\u0000CONCLUSION\u0000The change of alveolar structure at the base of apical lung blebs would increase the risk for recurrence of PSP after VATS bullectomy.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"44 1","pages":"139-45"},"PeriodicalIF":0.0,"publicationDate":"2016-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78465895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Cardiac Valve Noise Reduction by Non-Drug Interventions Improves the Sleep Quality of Patients after Mechanical Cardiac Valve Implantation. 通过非药物干预降低心脏瓣膜噪声可改善机械瓣膜植入术后患者的睡眠质量。
Yanjuan Lin, Le Xu, Xizhen Huang, F. Jiang, F. Lin, Q. Ye, Jianling Lin
PURPOSETo investigate the effects of non-drug interventions on the sleep quality of patients after mechanical cardiac valve implantation.METHODSIn this prospective, randomized, controlled trial, 64 patients scheduled for mechanical mitral valve replacement were recruited. Patients underwent cognitive behavioral therapy and wore noise cancelling earplugs and eye mask. Sleep quality was evaluated on the 4th after admission and the 5th days after operation. The primary outcome was the total sleep quality score differences between the 4th day after admission and the 5th day after operation.RESULTSAll patients had been suffering from poor sleep quality for a month before admission. There was no difference between both groups on the 4th day after admission. Overall sleep quality in the intervention group was better than in the control group on the 5th day after operation. The subjective sleep quality of the patients in each group was significantly lower on the 5th day after the operation than on the 4th day after admission (P <0.05).CONCLUSIONNon-drug intervention could improve the sleep quality of patients after mechanical cardiac valve implantation and help the postoperative recovery of the patients. (TRIAL REGISTRATIONChiCTR-TRC-14004405, 21 March 2014.).
目的探讨非药物干预对心脏机械瓣膜植入术后患者睡眠质量的影响。方法在这项前瞻性、随机、对照试验中,招募了64例计划进行机械二尖瓣置换术的患者。患者接受认知行为治疗,并戴上降噪耳塞和眼罩。分别于入院后第4天、术后第5天进行睡眠质量评价。主要观察指标为入院后第4天与术后第5天的总睡眠质量评分差异。结果所有患者入院前1个月均存在睡眠质量差。入院后第4天两组比较无差异。术后第5天,干预组患者整体睡眠质量优于对照组。各组患者术后第5天主观睡眠质量明显低于入院后第4天(P <0.05)。结论非药物干预可改善心脏机械瓣膜植入术患者的睡眠质量,有助于患者术后康复。(试验注册号:chictr - trc -14004405, 2014年3月21日)。
{"title":"Cardiac Valve Noise Reduction by Non-Drug Interventions Improves the Sleep Quality of Patients after Mechanical Cardiac Valve Implantation.","authors":"Yanjuan Lin, Le Xu, Xizhen Huang, F. Jiang, F. Lin, Q. Ye, Jianling Lin","doi":"10.5761/atcs.oa.15-00275","DOIUrl":"https://doi.org/10.5761/atcs.oa.15-00275","url":null,"abstract":"PURPOSE\u0000To investigate the effects of non-drug interventions on the sleep quality of patients after mechanical cardiac valve implantation.\u0000\u0000\u0000METHODS\u0000In this prospective, randomized, controlled trial, 64 patients scheduled for mechanical mitral valve replacement were recruited. Patients underwent cognitive behavioral therapy and wore noise cancelling earplugs and eye mask. Sleep quality was evaluated on the 4th after admission and the 5th days after operation. The primary outcome was the total sleep quality score differences between the 4th day after admission and the 5th day after operation.\u0000\u0000\u0000RESULTS\u0000All patients had been suffering from poor sleep quality for a month before admission. There was no difference between both groups on the 4th day after admission. Overall sleep quality in the intervention group was better than in the control group on the 5th day after operation. The subjective sleep quality of the patients in each group was significantly lower on the 5th day after the operation than on the 4th day after admission (P <0.05).\u0000\u0000\u0000CONCLUSION\u0000Non-drug intervention could improve the sleep quality of patients after mechanical cardiac valve implantation and help the postoperative recovery of the patients. (\u0000\u0000\u0000TRIAL REGISTRATION\u0000ChiCTR-TRC-14004405, 21 March 2014.).","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"80 1","pages":"69-75"},"PeriodicalIF":0.0,"publicationDate":"2016-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85811289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Pulmonary Myofibroblastic Tumour Involving the Pericardium and Left Atrium in an 18 Month Infant. 一例18个月婴儿肺肌成纤维细胞瘤累及心包和左心房。
R. Lamas-Pinheiro, G. Rodesch, C. Devalck, V. Segers, K. Khelif, M. Cappello, H. Steyaert
Inflammatory myofibroblastic tumor (IMT) is the most frequent primary lung tumor in children and it may be locally aggressive. The management of a locally advanced pulmonary IMT in an 18 month-old female child is presented.A left pulmonary mass was incidentally found on the computerized tomography (CT) scan of a child with persistent systemic inflammatory syndrome. Biopsy confirmed the diagnosis; after preoperative corticotherapy, left pneumonectomy was performed. The pericardium and left atrium were invaded and resected, requiring pericardial reconstruction. There is no relapse at four years of follow-up.Steroids play a role in tumor size reduction, but marginal resection is the gold standard. Extended approaches are feasible and often required in advanced cases.
炎症性肌纤维母细胞瘤(IMT)是儿童最常见的原发性肺肿瘤,它可能具有局部侵袭性。在一个18个月大的女婴局部进展肺IMT的管理提出。一位患有持续性全身性炎症综合征的儿童,在计算机断层扫描(CT)中偶然发现左肺肿块。活检证实了诊断;术前皮质治疗后,行左侧全肺切除术。心包和左心房被侵犯和切除,需要心包重建。随访四年无复发。类固醇在肿瘤缩小中起作用,但边缘切除是金标准。扩展的方法是可行的,并且在晚期病例中经常需要。
{"title":"Pulmonary Myofibroblastic Tumour Involving the Pericardium and Left Atrium in an 18 Month Infant.","authors":"R. Lamas-Pinheiro, G. Rodesch, C. Devalck, V. Segers, K. Khelif, M. Cappello, H. Steyaert","doi":"10.5761/ATCS.CR.15-00360","DOIUrl":"https://doi.org/10.5761/ATCS.CR.15-00360","url":null,"abstract":"Inflammatory myofibroblastic tumor (IMT) is the most frequent primary lung tumor in children and it may be locally aggressive. The management of a locally advanced pulmonary IMT in an 18 month-old female child is presented.A left pulmonary mass was incidentally found on the computerized tomography (CT) scan of a child with persistent systemic inflammatory syndrome. Biopsy confirmed the diagnosis; after preoperative corticotherapy, left pneumonectomy was performed. The pericardium and left atrium were invaded and resected, requiring pericardial reconstruction. There is no relapse at four years of follow-up.Steroids play a role in tumor size reduction, but marginal resection is the gold standard. Extended approaches are feasible and often required in advanced cases.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"03 1","pages":"312-314"},"PeriodicalIF":0.0,"publicationDate":"2016-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76304879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Factors Determining the Choice of Surgical Procedure in Elderly Patients with Non-Small Cell Lung Cancer. 决定老年非小细胞肺癌手术方式选择的因素。
J. Okamoto, H. Kubokura, J. Usuda
BACKGROUNDIn the elderly patients, optimal surgical treatment can be difficult to achieve, because of comorbidity. Therefore, we aimed to clarify the preferred surgical management in this patient group.METHODSA retrospective study was conducted between April 2008 and March 2015 that included patients with non-small cell lung cancer (NSCLC) aged ≥ 75 years.RESULTSWe included 44 patients who underwent partial resection (n = 20) or lobectomy (n = 24). There were no significant differences between the two groups on most variables, except for some character. Survival analysis revealed a significant difference in overall survival (OS) between the two groups; however, no significant differences existed in the disease-free survival or in the OS for stage I disease. Postoperative complications led to poor prognoses. Cox regression analysis revealed statistical significance for the Brinkman Index, the ratio of the pulmonary artery diameter to the ascending aorta diameter (PA:A), and the alveolar-arterial oxygen gradient. Only the PA:A ratio remained significant after multivariate analysis, with a higher ratio associated with better survival.CONCLUSIONIn elderly patients with NSCLC, surgical resection should not be denied because of age alone. However, partial resection should be favored to lobectomy when possible.
背景在老年患者中,由于合并症,最佳手术治疗可能难以实现。因此,我们旨在明确该患者组的首选手术治疗。方法回顾性研究于2008年4月至2015年3月进行,纳入年龄≥75岁的非小细胞肺癌(NSCLC)患者。结果我们纳入了44例接受部分切除(n = 20)或肺叶切除术(n = 24)的患者。除某些性状外,两组在大多数变量上均无显著差异。生存分析显示,两组总生存期(OS)差异有统计学意义;然而,在I期疾病的无病生存期或OS中没有显著差异。术后并发症导致预后不良。Cox回归分析显示Brinkman指数、肺动脉直径与升主动脉直径之比(PA:A)、肺泡-动脉氧梯度均有统计学意义。多变量分析后,只有PA:A比值保持显著性,比值越高生存率越好。结论对于老年非小细胞肺癌患者,不应仅仅因为年龄而拒绝手术切除。然而,在可能的情况下,部分切除应优于肺叶切除术。
{"title":"Factors Determining the Choice of Surgical Procedure in Elderly Patients with Non-Small Cell Lung Cancer.","authors":"J. Okamoto, H. Kubokura, J. Usuda","doi":"10.5761/atcs.oa.15-00365","DOIUrl":"https://doi.org/10.5761/atcs.oa.15-00365","url":null,"abstract":"BACKGROUND\u0000In the elderly patients, optimal surgical treatment can be difficult to achieve, because of comorbidity. Therefore, we aimed to clarify the preferred surgical management in this patient group.\u0000\u0000\u0000METHODS\u0000A retrospective study was conducted between April 2008 and March 2015 that included patients with non-small cell lung cancer (NSCLC) aged ≥ 75 years.\u0000\u0000\u0000RESULTS\u0000We included 44 patients who underwent partial resection (n = 20) or lobectomy (n = 24). There were no significant differences between the two groups on most variables, except for some character. Survival analysis revealed a significant difference in overall survival (OS) between the two groups; however, no significant differences existed in the disease-free survival or in the OS for stage I disease. Postoperative complications led to poor prognoses. Cox regression analysis revealed statistical significance for the Brinkman Index, the ratio of the pulmonary artery diameter to the ascending aorta diameter (PA:A), and the alveolar-arterial oxygen gradient. Only the PA:A ratio remained significant after multivariate analysis, with a higher ratio associated with better survival.\u0000\u0000\u0000CONCLUSION\u0000In elderly patients with NSCLC, surgical resection should not be denied because of age alone. However, partial resection should be favored to lobectomy when possible.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"11 1","pages":"131-8"},"PeriodicalIF":0.0,"publicationDate":"2016-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84168825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Robotic Surgery for Thoracic Disease. 胸腔疾病的机器人手术。
S. Yamashita, Y. Yoshida, A. Iwasaki
Robotic surgeries have developed in the general thoracic field over the past decade, and publications on robotic surgery outcomes have accumulated. However, controversy remains about the application of robotic surgery, with a lack of well-established evidence. Robotic surgery has several advantages such as natural movement of the surgeon's hands when manipulating the robotic arms and instruments controlled by computer-assisted systems. Most studies have reported the feasibility and safety of robotic surgery based on acceptable morbidity and mortality compared to open or video-assisted thoracic surgery (VATS). Furthermore, there are accumulated data to indicate longer operation times and shorter hospital stay in robotic surgery. However, randomized controlled trials between robotic and open or VATS procedures are needed to clarify the advantage of robotic surgery. In this review, we focused the literature about robotic surgery used to treat lung cancer and mediastinal tumor.
在过去的十年里,机器人手术在普通胸外科领域得到了发展,关于机器人手术结果的出版物也越来越多。然而,由于缺乏可靠的证据,关于机器人手术的应用仍然存在争议。机器人手术有几个优点,如外科医生的手在操纵机械臂和由计算机辅助系统控制的仪器时的自然运动。大多数研究报告了机器人手术的可行性和安全性,基于与开放或视频辅助胸外科手术(VATS)相比可接受的发病率和死亡率。此外,积累的数据表明,机器人手术的手术时间更长,住院时间更短。然而,需要在机器人手术与开放或VATS手术之间进行随机对照试验,以阐明机器人手术的优势。在这篇综述中,我们集中了关于机器人手术用于治疗肺癌和纵隔肿瘤的文献。
{"title":"Robotic Surgery for Thoracic Disease.","authors":"S. Yamashita, Y. Yoshida, A. Iwasaki","doi":"10.5761/atcs.ra.15-00344","DOIUrl":"https://doi.org/10.5761/atcs.ra.15-00344","url":null,"abstract":"Robotic surgeries have developed in the general thoracic field over the past decade, and publications on robotic surgery outcomes have accumulated. However, controversy remains about the application of robotic surgery, with a lack of well-established evidence. Robotic surgery has several advantages such as natural movement of the surgeon's hands when manipulating the robotic arms and instruments controlled by computer-assisted systems. Most studies have reported the feasibility and safety of robotic surgery based on acceptable morbidity and mortality compared to open or video-assisted thoracic surgery (VATS). Furthermore, there are accumulated data to indicate longer operation times and shorter hospital stay in robotic surgery. However, randomized controlled trials between robotic and open or VATS procedures are needed to clarify the advantage of robotic surgery. In this review, we focused the literature about robotic surgery used to treat lung cancer and mediastinal tumor.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"36 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2016-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89220406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Right Axillary Artery Cannulation in Aortic Valve Replacement. 主动脉瓣置换术中的右腋窝动脉插管。
M. Hosono, T. Shibata, T. Murakami, M. Sakaguchi, Yasuo Suehiro, S. Suehiro
OBJECTIVEThis retrospective study aimed to evaluate the results of our experience with axillary artery cannulation via a side graft in aortic valve replacement in patients with ascending aortic atherosclerotic disease.METHODSFrom January 2002 to 2012, we operated on 76 patients for aortic valve disease with the use of the axillary artery for arterial inflow in our institute. The indications for cannulation of the axillary artery were aortic aneurysm in 37 patients, severe aortic atherosclerosis in 28 patients, and re do surgery in 11 patients.RESULTSRight axillary artery cannulation via a side graft provides sufficient antegrade aortic flow of 2.6 ± 0.1 L/m(2) during cardiopulmonary bypass. No additional arterial cannulation was necessary to obtain sufficient perfusion during cardiopulmonary bypass. Although permanent perioperative stroke was observed in two patients, this did not occur during the operation. There were no problems with cannulation or wound and graft infections. During the follow-up period, there were no thrombotic events due to an axillary graft stump in the right upper extremities.CONCLUSIONSAxillary artery cannulation via a side graft is a useful and safe option for cardiopulmonary bypass in patients with atherosclerotic disease of the ascending aorta undergoing aortic valve replacement.
目的:本回顾性研究旨在评估我们在升主动脉粥样硬化性疾病患者主动脉瓣置换术中通过侧部移植物腋动脉插管的经验结果。方法2002年1月至2012年1月,我院共收治76例经腋动脉入路主动脉瓣病变患者。腋动脉插管指征为主动脉瘤37例,重度动脉粥样硬化28例,再手术11例。结果右腋窝动脉侧移植物插管在体外循环期间可提供2.6±0.1 L/m(2)的顺行主动脉流量。在体外循环期间,不需要额外的动脉插管来获得足够的灌注。尽管有2例患者观察到永久性围手术期卒中,但这并未在手术中发生。插管、伤口和移植物感染均无问题。在随访期间,没有由于右上肢腋窝移植物残端引起的血栓事件。结论对行主动脉瓣置换术的升主动脉动脉粥样硬化性疾病患者,经侧部移植物行腋动脉插管是一种安全有效的体外循环方法。
{"title":"Right Axillary Artery Cannulation in Aortic Valve Replacement.","authors":"M. Hosono, T. Shibata, T. Murakami, M. Sakaguchi, Yasuo Suehiro, S. Suehiro","doi":"10.5761/atcs.oa.15-00296","DOIUrl":"https://doi.org/10.5761/atcs.oa.15-00296","url":null,"abstract":"OBJECTIVE\u0000This retrospective study aimed to evaluate the results of our experience with axillary artery cannulation via a side graft in aortic valve replacement in patients with ascending aortic atherosclerotic disease.\u0000\u0000\u0000METHODS\u0000From January 2002 to 2012, we operated on 76 patients for aortic valve disease with the use of the axillary artery for arterial inflow in our institute. The indications for cannulation of the axillary artery were aortic aneurysm in 37 patients, severe aortic atherosclerosis in 28 patients, and re do surgery in 11 patients.\u0000\u0000\u0000RESULTS\u0000Right axillary artery cannulation via a side graft provides sufficient antegrade aortic flow of 2.6 ± 0.1 L/m(2) during cardiopulmonary bypass. No additional arterial cannulation was necessary to obtain sufficient perfusion during cardiopulmonary bypass. Although permanent perioperative stroke was observed in two patients, this did not occur during the operation. There were no problems with cannulation or wound and graft infections. During the follow-up period, there were no thrombotic events due to an axillary graft stump in the right upper extremities.\u0000\u0000\u0000CONCLUSIONS\u0000Axillary artery cannulation via a side graft is a useful and safe option for cardiopulmonary bypass in patients with atherosclerotic disease of the ascending aorta undergoing aortic valve replacement.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"1 1","pages":"84-9"},"PeriodicalIF":0.0,"publicationDate":"2016-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85556339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Heparin-Induced-Thrombocytopenia Causing Massive Aortic Thrombosis after Ascending Aortic Replacement for Type A Acute Aortic Dissection. 肝素诱导的血小板减少导致A型急性主动脉夹层升主动脉置换术后主动脉血栓形成。
Y. Matsuki, K. Imoto, K. Uchida, S. Isoda, N. Karube, S. Yasuda, M. Masuda
A 77-year-old woman underwent emergency ascending aortic replacement for type A acute aortic dissection. Fifteen days after the operation, she had motor and sensory disturbances in the lower limbs. Computed tomography revealed multiple aortic thrombi and disrupted blood flow in the right external iliac and left common iliac arteries. She underwent an emergency thrombectomy for acute limb ischemia. Because heparin-induced-thrombocytopenia (HIT) was suspected to have caused the multiple aortic thrombi, we postoperatively changed the anticoagulant therapy from heparin to argatroban. Seventeen days after the first operation, gastrointestinal bleeding developed, and the patient died of mesenteric ischemia caused by HIT. Arterial embolization caused by HIT after cardiovascular surgery is a rare, but fatal event. To avoid fatal complications, early diagnosis and early treatment are essential. Use of a scoring system would probably facilitate early diagnosis.
一位77岁的女性因A型急性主动脉夹层接受了紧急升主动脉置换术。手术后15天,她出现了下肢运动和感觉障碍。计算机断层扫描显示多发主动脉血栓,右髂外动脉和左髂总动脉血流中断。她因急性肢体缺血接受了紧急血栓切除术。由于肝素诱导的血小板减少症(HIT)被怀疑是导致多发主动脉血栓的原因,我们在术后将抗凝治疗从肝素改为阿加曲班。第一次手术后17天出现胃肠出血,患者死于HIT引起的肠系膜缺血。心血管手术后HIT引起的动脉栓塞是一种罕见但致命的事件。为了避免致命的并发症,早期诊断和早期治疗至关重要。使用评分系统可能有助于早期诊断。
{"title":"Heparin-Induced-Thrombocytopenia Causing Massive Aortic Thrombosis after Ascending Aortic Replacement for Type A Acute Aortic Dissection.","authors":"Y. Matsuki, K. Imoto, K. Uchida, S. Isoda, N. Karube, S. Yasuda, M. Masuda","doi":"10.5761/ATCS.CR.15-00345","DOIUrl":"https://doi.org/10.5761/ATCS.CR.15-00345","url":null,"abstract":"A 77-year-old woman underwent emergency ascending aortic replacement for type A acute aortic dissection. Fifteen days after the operation, she had motor and sensory disturbances in the lower limbs. Computed tomography revealed multiple aortic thrombi and disrupted blood flow in the right external iliac and left common iliac arteries. She underwent an emergency thrombectomy for acute limb ischemia. Because heparin-induced-thrombocytopenia (HIT) was suspected to have caused the multiple aortic thrombi, we postoperatively changed the anticoagulant therapy from heparin to argatroban. Seventeen days after the first operation, gastrointestinal bleeding developed, and the patient died of mesenteric ischemia caused by HIT. Arterial embolization caused by HIT after cardiovascular surgery is a rare, but fatal event. To avoid fatal complications, early diagnosis and early treatment are essential. Use of a scoring system would probably facilitate early diagnosis.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"9 1","pages":"318-321"},"PeriodicalIF":0.0,"publicationDate":"2016-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79501367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Arterial Vasoreactivity is Equally Affected by In Vivo Cross-Clamping with Increasing Loads in Young and Middle-Aged Mice Aortas. 随着负荷的增加,体内交叉夹紧对中青年小鼠主动脉血管反应性的影响是相同的。
R. Geenens, N. Famaey, A. Gijbels, Valérie Verhulst, S. Vinckier, J. Vander Sloten, P. Herijgers
PURPOSE To compensate for the lack of haptic feedback by surgical robots, limitation of exerted forces could be implemented. The limits should be based on the observed relationship between tissue load and induced damage. This study examines whether age-related changes influence this relationship. METHODS Descending thoracic aortas of male C57BL/6J mice of 10, 25 and 40 weeks were clamped in vivo (no clamp, 0.5N or 2.0N) for 2 min. Functional integrity was tested in vitro by studying endothelium-dependent and -independent vasoreactivity. RESULTS Endothelium-dependent relaxation deteriorated with increased clamping force at all ages. Clamping did not influence endothelium-independent vasodilation. Age (10, 25 and 40 weeks) did not significantly impact on the effect of clamping on endothelium-dependent and independent vasoreactivity. CONCLUSIONS Within the tested conditions, mechanical clamping induces damage to the vascular endothelium, but not to the smooth muscle cells. Age has no effect on the obtained results in mice from 10 to 40 weeks old.
目的:为弥补手术机器人触觉反馈不足的缺陷,可以对手术机器人施加的作用力进行限制。极限应基于观察到的组织负荷和诱导损伤之间的关系。这项研究考察了与年龄相关的变化是否会影响这种关系。方法将10、25、40周龄雄性C57BL/6J小鼠胸降主动脉在体内夹持(不夹持、0.5N、2.0N) 2 min,通过内皮依赖性和非依赖性血管反应性检测其体外功能完整性。结果随夹紧力的增加,各年龄层的硒依赖性松弛程度逐渐恶化。夹紧不影响内皮非依赖性血管舒张。年龄(10、25和40周)对夹持对内皮依赖和独立血管反应性的影响没有显著影响。结论在实验条件下,机械夹紧对血管内皮有损伤,对平滑肌细胞无损伤。年龄对10至40周龄小鼠的所得结果没有影响。
{"title":"Arterial Vasoreactivity is Equally Affected by In Vivo Cross-Clamping with Increasing Loads in Young and Middle-Aged Mice Aortas.","authors":"R. Geenens, N. Famaey, A. Gijbels, Valérie Verhulst, S. Vinckier, J. Vander Sloten, P. Herijgers","doi":"10.5761/atcs.oa.15-00225","DOIUrl":"https://doi.org/10.5761/atcs.oa.15-00225","url":null,"abstract":"PURPOSE To compensate for the lack of haptic feedback by surgical robots, limitation of exerted forces could be implemented. The limits should be based on the observed relationship between tissue load and induced damage. This study examines whether age-related changes influence this relationship. METHODS Descending thoracic aortas of male C57BL/6J mice of 10, 25 and 40 weeks were clamped in vivo (no clamp, 0.5N or 2.0N) for 2 min. Functional integrity was tested in vitro by studying endothelium-dependent and -independent vasoreactivity. RESULTS Endothelium-dependent relaxation deteriorated with increased clamping force at all ages. Clamping did not influence endothelium-independent vasodilation. Age (10, 25 and 40 weeks) did not significantly impact on the effect of clamping on endothelium-dependent and independent vasoreactivity. CONCLUSIONS Within the tested conditions, mechanical clamping induces damage to the vascular endothelium, but not to the smooth muscle cells. Age has no effect on the obtained results in mice from 10 to 40 weeks old.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"40 1","pages":"38-43"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79646617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum(®) Injection) for Malignant Pleural Effusion. 利用槲寄生提取液(ABNOVAviscum(®)注射液)进行化学胸膜切除术治疗恶性胸腔积液。
J. Cho, K. Na, Yongjik Lee, Y. Kim, H. Ahn, C. Park, YOUNG CHUL Kim
PURPOSE Malignant pleural effusion (MPE) is common in patients with advanced cancer. Chemical pleurodesis can be considered for MPE that do not respond to chemotherapy, radiotherapy, or therapeutic thoracentesis. However, it is not yet clear which agent is more effective and safer in chemical pleurodesis. METHODS This study was designed as a single arm, multicenter, and open-label phase III clinical trial to evaluate efficacy and safety of chemical pleurodesis using mistletoe extraction (ABNOVAviscum(®) Injection). References of other agents in chemical pleurodesis were investigated to compare efficacy and safety. Efficacy was evaluated by followed up chest X-ray and changes of clinical symptoms and Karnofsky performance scale. Safety was evaluated by serious adverse event (SAE) and changes of laboratory findings. A follow-up period was 4 weeks after last pleurodesis. RESULTS Of 62 patients, 49 (79.0%) had complete response, 11 (17.7%) had partial response, and two had no response. Mean response rate was significantly different in this study comparing with reference response rate which was 64% (p <0.0001). There were two SAEs, but all were recovered without sequelas. CONCLUSION The results of this study suggest that mistletoe extraction (ABNOVAviscum(®) Injection) could be an effective and safe agent of chemical pleurodesis in patients with MPE.
目的恶性胸腔积液(MPE)在晚期癌症患者中较为常见。对于化疗、放疗或治疗性胸腔穿刺无效的MPE,可以考虑化学胸膜穿刺术。然而,目前尚不清楚哪种药物在化学胸膜穿刺术中更有效、更安全。方法本研究设计为单臂、多中心、开放标签的III期临床试验,以评估槲寄生提取物(ABNOVAviscum(®)注射液)化学胸膜切除术的有效性和安全性。对其他药物在化学胸膜穿刺术中的疗效和安全性进行了比较。通过随访胸片、临床症状变化及Karnofsky表现量表评价疗效。通过严重不良事件(SAE)和实验室检查结果的变化来评估安全性。最后一次胸膜融合术后随访4周。结果62例患者中,完全缓解49例(79.0%),部分缓解11例(17.7%),无缓解2例。本研究的平均有效率与参考有效率64%有显著差异(p <0.0001)。有2例急性呼吸道感染,但均痊愈,无后遗症。结论槲寄生提取物(ABNOVAviscum(®)注射液)是一种安全有效的治疗MPE患者化学胸膜切除术的药物。
{"title":"Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum(®) Injection) for Malignant Pleural Effusion.","authors":"J. Cho, K. Na, Yongjik Lee, Y. Kim, H. Ahn, C. Park, YOUNG CHUL Kim","doi":"10.5761/atcs.oa.15-00230","DOIUrl":"https://doi.org/10.5761/atcs.oa.15-00230","url":null,"abstract":"PURPOSE Malignant pleural effusion (MPE) is common in patients with advanced cancer. Chemical pleurodesis can be considered for MPE that do not respond to chemotherapy, radiotherapy, or therapeutic thoracentesis. However, it is not yet clear which agent is more effective and safer in chemical pleurodesis. METHODS This study was designed as a single arm, multicenter, and open-label phase III clinical trial to evaluate efficacy and safety of chemical pleurodesis using mistletoe extraction (ABNOVAviscum(®) Injection). References of other agents in chemical pleurodesis were investigated to compare efficacy and safety. Efficacy was evaluated by followed up chest X-ray and changes of clinical symptoms and Karnofsky performance scale. Safety was evaluated by serious adverse event (SAE) and changes of laboratory findings. A follow-up period was 4 weeks after last pleurodesis. RESULTS Of 62 patients, 49 (79.0%) had complete response, 11 (17.7%) had partial response, and two had no response. Mean response rate was significantly different in this study comparing with reference response rate which was 64% (p <0.0001). There were two SAEs, but all were recovered without sequelas. CONCLUSION The results of this study suggest that mistletoe extraction (ABNOVAviscum(®) Injection) could be an effective and safe agent of chemical pleurodesis in patients with MPE.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"57 1","pages":"20-6"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82534774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Surgery of the Ascending Aorta with or without Combined Procedures through an Upper Ministernotomy: Outcomes of a Series of More Than 100 Patients. 通过上胸骨切开术联合或不联合升主动脉手术:100多例患者的结果
S. Lentini, L. Specchia, S. Nicolardi, F. Mangia, Olivera Rasovic, G. Di Eusanio, R. Gregorini
BACKGROUND Use of a minimally invasive approach for isolated aortic valve surgery is increasing. However, management of the root and/or ascending aorta through a mini-invasive incision is not so frequent. The aim of this study is to report our initial experience with surgery of the ascending aorta through a ministernotomy approach. METHODS We retrospectively analyzed 102 patients treated for ascending aorta disease through a ministernotomy. Several types of surgeries were performed, including isolated or combined surgical procedures. Pre-operative and operative parameters and in-hospital clinical outcomes were retrospectively analyzed. RESULTS Patient mean age was 63.9 ± 13.6 years (range 29-85). There were 33 (32.4%) female and 69 (67.6%) male patients. Preoperative logistic EuroSCORE I was 7.4% ± 2.1%. Mean cardiopulmonary bypass and aortic cross-clamp time were 123.7 ± 36.9 and 100.8 ± 27.5 min, respectively. In-hospital mortality was 0%. CONCLUSIONS Our experience shows that surgery of the ascending aorta with or without combined procedures can be safely performed through an upper ministernotomy, without compromising surgical results. Although our series is not large, we believe that the experience gained on the isolated aortic valve through a ministernotomy can be safely reproduced in ascending aorta surgery as a routine practice.
背景:微创入路在孤立主动脉瓣手术中的应用越来越多。然而,通过微创切口处理根和/或升主动脉的情况并不常见。本研究的目的是报告我们通过小段切开术的升主动脉手术的初步经验。方法回顾性分析102例经胸骨切开术治疗升主动脉疾病的患者。进行了几种类型的手术,包括单独或联合手术。回顾性分析术前、术中参数及院内临床结果。结果患者平均年龄为63.9±13.6岁(29 ~ 85岁)。其中女性33例(32.4%),男性69例(67.6%)。术前logistic EuroSCORE I为7.4%±2.1%。平均体外循环时间为123.7±36.9 min,主动脉交叉夹持时间为100.8±27.5 min。住院死亡率为0%。结论我们的经验表明,无论是否采用联合手术,升主动脉手术均可通过上胸骨切开术安全进行,且不会影响手术效果。虽然我们的研究范围并不大,但我们相信通过小瓣切开术获得的孤立主动脉瓣的经验可以作为常规手术安全地在升主动脉手术中复制。
{"title":"Surgery of the Ascending Aorta with or without Combined Procedures through an Upper Ministernotomy: Outcomes of a Series of More Than 100 Patients.","authors":"S. Lentini, L. Specchia, S. Nicolardi, F. Mangia, Olivera Rasovic, G. Di Eusanio, R. Gregorini","doi":"10.5761/atcs.oa.15-00245","DOIUrl":"https://doi.org/10.5761/atcs.oa.15-00245","url":null,"abstract":"BACKGROUND Use of a minimally invasive approach for isolated aortic valve surgery is increasing. However, management of the root and/or ascending aorta through a mini-invasive incision is not so frequent. The aim of this study is to report our initial experience with surgery of the ascending aorta through a ministernotomy approach. METHODS We retrospectively analyzed 102 patients treated for ascending aorta disease through a ministernotomy. Several types of surgeries were performed, including isolated or combined surgical procedures. Pre-operative and operative parameters and in-hospital clinical outcomes were retrospectively analyzed. RESULTS Patient mean age was 63.9 ± 13.6 years (range 29-85). There were 33 (32.4%) female and 69 (67.6%) male patients. Preoperative logistic EuroSCORE I was 7.4% ± 2.1%. Mean cardiopulmonary bypass and aortic cross-clamp time were 123.7 ± 36.9 and 100.8 ± 27.5 min, respectively. In-hospital mortality was 0%. CONCLUSIONS Our experience shows that surgery of the ascending aorta with or without combined procedures can be safely performed through an upper ministernotomy, without compromising surgical results. Although our series is not large, we believe that the experience gained on the isolated aortic valve through a ministernotomy can be safely reproduced in ascending aorta surgery as a routine practice.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"22 1","pages":"44-8"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82557850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
期刊
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1